Intended for healthcare professionals

Letters Test results and transgender care

Reporting reference ranges specific to trans and non-binary people on hormone therapy

BMJ 2022; 377 doi: https://doi.org/10.1136/bmj.o1093 (Published 20 May 2022) Cite this as: BMJ 2022;377:o1093
  1. Devon Buchanan, clinical scientist
  1. Blood Science Laboratory, Bessemer Wing, King’s College Hospital, London, UK
  1. devon.buchanan{at}nhs.net

I disagree with Cheung and colleagues’ call for both male and female reference ranges to be reported (dual reporting) for all tests with sex specific reference ranges.1 I think medical laboratories should automatically report reference ranges that are specific to trans and non-binary people on hormone therapy.

The first reason that Cheung and colleagues give for dual reporting is …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription